Microsoft Word - ASX Announcement - CE trial FinalThe %SSG Take had a mean of 81.9% and a median of 88.6%. Independent statistical analysis comparedthe %SSG Take to a target value of 77% derived from results published in the literature for other dermalmatrices. After transformation to allow for the non-normal distribution of the data, the mean %SSG Takeover BTM was significantly greater than 77% (p = 0.031) thereby demonstrating superiority.
Statistically significant data for primary endpoint results is the biggest thing to come from this. Further strengthening our case as a clinically superior product. Well done.
Ann: CE Mark Burn Trial Results, page-3
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PNV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.45 |
Change
0.010(0.41%) |
Mkt cap ! $1.691B | |||
| Open | High | Low | Value | Volume |
| $2.45 | $2.51 | $2.43 | $5.243M | 2.122M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 35541 | $2.45 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.46 | 2681 | 1 |
View Market Depth
| Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
| PNV (ASX) Chart |